IN THE NEWS: CAR T vs. Stem Cell Transplant for Multiple Myeloma

Patient Power

Currently, multiple myeloma (MM) is uncurable, so oncologists try to find treatment options that will control the disease. Abhinav Deol, M.D., hematologist, medical oncologist, and member of the Bone Marrow and Stem Cell TransplantHematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, explained the success rates for using CAR T cell therapy to treat MM or stem cell transplantation.

Read the article here.